Loyola University Chicago

Department of Biology

Programs

News

A final exam in treating the human condition for nursing students

A final exam in treating the human condition for nursing students

Jennifer Zitzner teaches her Anatomy and Physiology lab in the Life Science Building on January 26, 2016. Jennifer's previous class is honoring her mother's fight with cancer by doing Relay for Life in her honor this spring. (photo by Natalie Battaglia)
The full story: here

8th Beauty in Biology 2017-2018 Competition

Eligibility: LUC undergraduate or graduate students in any major, as well as alumni.   

Submission deadline: April 1st, 2019*

1st Prize: $1000.00       

Collaboration between science majors and artists is encouraged

Click  for full contest details

‌*Please email Prof. Bill Rochlin, wrochli@luc.edu, and provide an estimate of the anticipated size of your work by March 1, 2019  (earlier is better).


Before Our Eyes
Lisa Kim
Winner, 7th BnB competition, April 2018

Frontiers in Science Symposium

Dr. John Dye Presents
FLIPPING YOUR MINDSET: An Ebola Inspired Tale
Wed., March 21, 4:30-5:30pm
Sullivan Center - Galvin Auditorium

As the Chief of Viral Immunology within the Virology Division at USAMRIID, Dr. Dye oversees the execution of research programs in medical countermeasures against viral biological warfare agents in a high-hazard, multi-suite, biocontainment laboratory that operates at Biosafety Levels 2, 3, and 4. Dr. Dye’s research focuses on filovirus vaccines and therapeutics, with the ultimate aim to counteract the Ebola virus and other high risk pathogens.  Dr. Dye is on the cutting edge of research and development of medical countermeasures against filoviruses (e.g., Ebola virus, Sudan virus, and Marburg virus) and other biological threat agents. Since 2012, Dr. Dye has been traveling to Uganda to track the immune response in over 200 survivors of Ebola virus disease. Specifically, he assesses the immune responses of these survivors over time in hopes of determining an “immune profile” to drive vaccine and therapeutic development for the future. His extensive network of research collaborators has influenced basic science research on various aspects of virology and immunology, including the identification and publication of filovirus and Lassa virus receptors in the journals Nature and Science, respectively. These findings have driven protein-specific medical countermeasures against both viruses in order to provide a treatment option.